Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer
- 31 July 2008
- journal article
- Published by Elsevier BV in Nuclear Medicine and Biology
- Vol. 35 (5), 589-597
- https://doi.org/10.1016/j.nucmedbio.2008.03.003
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Radionuclide Liver Cancer Therapies: From Concept to Current Clinical StatusAnti-Cancer Agents in Medicinal Chemistry, 2007
- 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Advances in Nuclear Oncology: Microspheres for Internal Radionuclide Therapy of Liver TumoursCurrent Medicinal Chemistry, 2002
- Estimating the world cancer burden: Globocan 2000International Journal of Cancer, 2001
- Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study.European Journal of Nuclear Medicine and Molecular Imaging, 2001
- Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniquesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Hepatic tumor radioembolization in a rat model using radioactive rhenium (186Re/188Re) glass microspheresInternational Journal of Radiation Oncology*Biology*Physics, 1999
- The role of multimodal therapy in the treatment of hepatocellular carcinomaCancer, 1994
- Regional delivery of microspheres to liver metastases: the effects of particle size and concentration on intrahepatic distributionBritish Journal of Cancer, 1991
- Distribution of different sized microspheres in experimental hepatic tumoursEuropean Journal of Cancer and Clinical Oncology, 1987